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SPECIES-SPECIFIC EXPRESSION OF TYPE 
TGF-ß RECEPTOR ISOFORMS BY ARTICULAR
CHONDROCYTES: EFFECT OF PROTEOGLYCAN
DEPLETION AND AGING
H. L. G lansbeek ,1 P. M. van der K ra a n ,1 F. P. J. G. Lafeber,2 E. L. Vitters,
W. B. van den Berg1
« N *
Recently, a new isoform of the type II transforming growth factor beta receptor (TGF-PRII) 
was identified. This isoform (TGF-pRIl2) contains an insertion of 25 amino acids in the 
extracellular domain of the receptor. Using RT-PCR the authors demonstrated that both
TGF-pRIIi and TGF-pRIlj are expressed by chondrocytes in murine and human articular
cartilage. Bovine articular chondrocytes expressed TGF-pRIIi mRNA but did not express 
detectable levels of TGF-pRII2 mRNA, suggesting that the new isoform does not play an 
important role in normal bovine cartilage physiology. Because TGF-p responses seem to be age 
related and differential TGF-p responses have been described between normal cartil age and 
cartilage undergoing repair the authors studied if the relative mRNA expression between these 
isoforms is altered during cartilage repair and aging. No differences in the relative mRNA 
expression of the two isoforms of the type II TGF-p receptor could be demonstrated in murine 
cartilage during aging or during the repair phase after mild PG depletion indicating that it is 
unlikely that age-related TGF-p responses and differential TGF-P responses between normal 
cartilage and cartilage undergoing repair are the result of differences in the relative expression 
of the two TGF-PRII isoforms.
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Transforming growth factor beta (TGF-p) is a 
potent regulator of cell metabolism.1,2 A role of TGF-P 
in cartilage physiology is suggested by the presence 
of high concentrations of TGF-P in normal articular 
cartilage3 and its regulatory role in chondrocyte 
proliferation, differentiation and extracellular matrix 
production.4 11 Since TGF-p expression in the joint is 
enhanced in with rheumatoid arthritis 
and active TGF-P is present in the synovial fluid of 
patients with rheumatoid arthritis or osteoarthritis14 
it is assumed that TGF-p also plays a role in
regulation of chondrocyte during these
TGF-ß responses are by specific cell
surface receptors. Articular chondrocytes express at 
least four distinct types of TGF-p receptors: 
type II, type III and type V TGF-p receptors.1,15
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type I and type II TGF-ß receptors seem to be the most
important TGF-ß 
involved in signal tn
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are directly
a new of the type II TGF-ß 
from a mouse brainreceptor was
bank,21 a human glioblastoma cDNA bank-1” and from
a an endothelial cDNA bank.-'' This new
isoform (TGF-PRII2 ) contains an insertion of 25 amino 
acids in the extracellular domain of the receptor. It is 
most likely that this isoform is generated by differential 
splicing of mRNA that is transcribed from the original 
type II TGF-P receptor gene. An i tant role of
this isoform is suggested because the insertion of the 
human isoform and the murine isoform are localized at
same site and the amino acid
insertion is between
of the
(76% identical).21 It has been shown that TGF-ßRIh
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Figure 1. Expression of TGF-|JRIIiand TGF-pRIUmRNA in normal bovine (B), murine (M) and human 
(H) articular cartilage.
Total RNA was isolated from normal articular cartilage and RT-PCR was performed. PCR products 
are separated on a 1.6% agarose gel. Each lane shows the products of RT-PCR using RNA from 
different donors. RNA from human and bovine cartilage was isolated form individual donors while 
RNA of murine cartilage was isolated from pooled patellar cartilage of live mice.
Because TGF-ß effects on articular cartilage seem to be
age related“4"-7 and differential TGF-P responses have 
been described between normal cartilage and cartilage 
undergoing repair,28 30 the authors also studied if the 
relative expression of TGF-pRII, and TGF-PRII2 is 
altered during aging or during matrix repair after PG 
depletion.
R E SU LT S
TGF-pRIh and TGF-fiRIL mRNA expression in 
normal cartilage
RT-PCR on isolated RNA from human and 
murine articular cartilage using TGF-PRII specific 
primers resulted in two PCR products. The sizes of the 
PCR products corresponded to the expected size 
of amplified TGF-PRII, mRNA (525 bp) and TGF- 
PRII2 mRNA (601 bp) demonstrating that both 
TGF-pRII 1 and TGF~PRII2 mRNA are expressed 
in normal articular cartilage. However, there were 
striking differences in the relative expression of the 
two isoforms between species. Murine articular
expressed almost equal amounts of 
TGF-PRII, and TGF-PRII, mRNA, while human
articular chondrocytes :ibout three times
24 27
more TGF-PRII, mRNA than TGF-PRII, mRNA.
When RNA from bovine articular chondrocytes was 
used only TGF-pRII, mRNA was detected demon­
strating that the expression of the TGF-PRII2 isoform 
is very low or absent (Fig. 1).
TGF-pRIIt and TGF-pRII2 mRNA expression in
cartilage o f  different age
It has been reported that TGF-P has different 
effects on old cartilage compared to young cartilage.
To investigate if these age-related TGF-P responses are 
the result of differences in the relative expression of 
the two isoforms of the TGF-p type II receptor the 
authors determined the relative mRNA expression of 
TGF-PRII, and TGF-PRII2 in murine articular 
cartilage of different ages. RNA was isolated from 
patellar cartilage 3,6, 12, 18 and 24 months of age, and 
RT-PCR was performed. As shown in Fig. 2, articular 
cartilage from mice of all ages express both TGF-PRII 1 
and TG F-pRII2 mRNA. No differences could be 
demonstrated in the relative expression of TGF-PRII, 
and TGF-PRII2 mRNA between 3 months old (young 
adult) cartilage and cartilage up to 24 months of age 
(very old).
TGF-pRII, and TGF-pRII2 mRNA expression in
cartilage during a repair phase
Because differential TGF-P responses have also 
been described between normal cartilage and cartilage
Sflï • i
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Figure 2. Expression of TGF-pRIIiand TGF-pRIhmRNA in murine articular cartilage 
between 3 and 24 months of age.
RT-PCR was performed using RNA isolated from patellar articular cartilage of different 
age. RNA was isolated from pooled patellar cartilage of live mice. Shown is a 
representative experiment of three.
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Figure 3. Effect of intra-articular injection of 0.5% papain on the PG 
synthesis of patellar cartilage.
Glycosaminoglycan synthesis was measured ex vivo by [35S]sulfate 
incorporation using five patellae at each point of time. The results 
are expressed as percentage of [35S]sulfate incorporation of patellar 
cartilage from joints which were intra-articular injected with saline. 
Shown is a representative experiment of three.
undergoing repair after cartilage injury11'28,29 whether 
the relative expression of TGF-(3RII| and TGF-PRIL 
mRNA is altered during the repair phase after mild PG 
depletion was investigated. A murine cartilage repair 
model was used in which 0.5% papain was injected 
in the murine knee joint. Intra-articular injection of 
papain results in PG depletion31 and an inhibition of 
the PG synthesis up to 50% at one day after injection 
(Fig. 3). The PG synthesis is normalized between 
three and four days after injection whereafter the 
PG synthesis is supranormal up to 14 days with a 
maximal stimulation at 7 days after injection. The 
relative TGF-j3RIL and TGF-PRIL mRNA expression 
in cartilage was determined by RT-PCR at different 
points of time after injection of papain. No differences 
in the relative mRNA expression of the two isoforms 
could be demonstrated between normal articular 
cartilage and cartilage after papain treatment on any 
point of time (Fig. 4).
DISCUSSION
Recently a new isoform of the type II TGF-ß
receptor was identified. This new isoform (TGF- 
ßRIL) contains an insertion of 25 amino acids in the 
extracellular domain of the receptor. An important role 
of this isoform is suggested by the high conservation of 
this insertion between species. Since the original type II 
receptor (TGF-ßRIIi) has a low affinity for TGF-ß232,33 
it was investigated whether the new isoform was a 
TGF-ß2-specific receptor. However, binding studies 
using transfected cells showed that TGF-ßRIL also had 
a much higher affinity for TGF-ßl than for TGF-ß2.21,23 
These results indicate that the new isoform is not a 
TGF-ß2-specific receptor. Transfection studies using 
a TGF-ß resistant cell line which lacks endo­
genous TGF-ßRII demonstrated that TGF-ßRIIi 
and TGF-ßRIL were indistinguishable in their 
biological functions.23 However, these studies are 
non-physiological and limited to only a few specific 
TGF-ß responses.
Using RT-PCR it has been demonstrated for 
the first time that both TGF-ßRIIi and TGF-ßRIL 
mRNA are expressed in normal human and murine 
articular cartilage. The authors were not able to detect 
TGF-ßRIL mRNA in bovine articular chondrocytes. 
Although murine primers were used in these studies we 
can exclude the possibility that the inability to detect 
TGF-ßRIL mRNA in bovine articular chondrocytes is 
an artefact due to differences in the primer-annealing
sequences. Both TGF-ßRIIi and TGF-ßRIL mRNA
were amplified in the same tube, using the same primers 
and under the same conditions so the isoforms are 
internal controls for each other. Since TGF-ßRIIi 
mRNA could be detected in bovine chondrocytes it can 
be concluded that bovine articular chondrocytes do not 
express TGF-ßRIL mRNA or express this isoform at 
a very low level. This implicates that it is unlikely 
that TGF-ßRIL plays an essential role in the 
metabolism of normal bovine articular cartilage.
TGF-ß responses on articular chondrocytes are
shown to be age related.24-27 For example, articular
•TGF-ßRII2
■TGF-ßRIL
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Figure 4. Expression of TGF-pRIIiand TGFpRII2mRNA in patellar cartilage after PG depletion.
Murine patellae were dissected at several points of time after intra-articular injection of 0.5% papain 
(P) or saline (C). RNA was isolated from pooled patellar cartilage of five mice. RT-PCR was 
performed and the PCR products are separated on a 1.6% agarose gel. Shown is a representative
experiment of three.
350 / Glansbeek et al. CYTOKINE, Vol. 9, No. 5 (May, 1997: 347-351)
cartilage from old adult pigs is more sensitive to TGF-P 
induced elaboration of extracellular inorganic pyro-
phosphate (ePPi) than from juvenile and
young adult pigs.26 Young murine articular cartilage 
appears to be more sensitive to TGF-P-induced 
stimulation of PG synthesis than old murine articular
cartilage.-5 Because various TGF-P responses are 
age related, the authors investigated if one of the 
isoforms is selectively upregulated during aging. 
However, it was demonstrated that the ratio between 
TGF-PRII, and TG F-pRII2 mRNA does not differ 
in murine articular cartilage between 3 months and 
24 months of age. These results suggest that the 
described differentiell TGF-P responses between old 
and young articular cartilage are not mediated by 
differences in the relative expression of the two 
isoforms of TGF-PRII.
It has also been demonstrated that T G F -ß  has 
different effects on normal articular cartilage and 
cartilage during a repair phase. For example, TGF-P 
stimulated PG synthesis of human osteoarthritic 
cartilage while under the same conditions TGF-P did 
not have a significant effect on the PG synthesis of 
normal human cartilage.29 In addition, TGF-p en­
hanced the PG synthesis of interleukin 1 (IL-l)-treated 
cartilage but the effects of TGF-ß on normal cartilage 
PG synthesis were minimal.2X30 The relative expression 
of TGF-pRII, and TGF-pRII, mRNA in the repair 
phase after mild PG depletion was investigated. Mild 
PG depletion in murine articular cartilage was induced 
by injection of 0.5% papain in the murine knee 
joint. No differences in the relative expression of 
TGF-pRII, and TG F-PRII2 mRNA could be demon­
strated between normal cartilage and cartilage under­
going repair after mild PG depletion. This indicates 
that the supranormal PG synthesis after PG depletion 
by papain is not mediated by selective upregulation 
of mRNA of one of the two isoforms. This also suggests
that described differentia] TGF-P
between normal cartilage and cartilage 
repair” 1(1 are not the result of differences in the relative 
expression of TGF-PRII, and TGF-PR1I2 mRNA.
In summary, this study that
newly identified isoform of the type II TGF-p receptor 
(TGF-pRII2) is expressed in normal human and murine
a í ' ar cartilage. TGF-PRII2 mRNA was not 
detectable in bovine articular cartilage indicating that 
it is unlikely that TG F-pRII2 plays an important role 
in the physiology of normal bovine articular cartilage. 
No differences in the relative mRNA expression of the 
two isoforms of the type II TGF-p receptor could be 
demonstrated in murine cartilage during aging or
d u r i n g repair phase after PG depletion
indicating that it is unlikely that age related TGF-P 
responses and differential TGF-p responses 
normal cartilage and cartilage undergoing repair are
the result of differences in the relative expression of the 
two TGF-PRII iso forms.
M A TER IA LS A N D  M E T H O D S
A nimals
Male C57B1/10 mice were used to study age-related 
differences. Male C57B1/6 mice were used in experiments in 
which cartilage depletion was induced. Mice were kept in 
cages with a wood chip bedding in a room kept at constant 
temperature. They were fed a standard diet and tap water ad
Isolation of cartilage
Murine articular cartilage was isolated from patellae. 
Patellae were decalcified in 3.5% EDTA for 4 h at 4"C, when 
the whole cartilage layer was stripped off. Because old 
cartilage is more calcified, décalcification of patellae of 
old mice (> 3  month) was performed overnight at 4 ’C. In 
control experiments it was demonstrated that décalcification 
by EDTA does not affect efficiency of RNA isolation or 
RT-PCR (data not shown). Bovine cartilage was isolated 
from metacarpophalangeal joints within 8 h after death of the 
animals. Human cartilage was isolated from femoral knee 
condyles within 18 h after death of the donor. Only cartilage 
samples which were histologically defined as normal were 
used. Isolated human and bovine articular cartilage was 
immediately frozen in liquid nitrogen.
RNA isolation and RT-PCR
Total RNA was isolated using TRIzol Reagent (Life 
Technologies). Human and bovine articular cartilage was 
ground to powder in a freeze mill and defrosted in TRIzol. 
Murine articular cartilage was directly after isolation 
extracted with TRIzol. Before reverse transcription total 
RNA was treated with DNase (Life Technologies). Reverse
transcription was performed with M-MLV Reverse Tran­
scriptase (Life Technologies) using ithc 3' PCR primer. Taq 
DNA Polymerase (Life Technologies) was used in the PCR 
reaction. cDNA was cycled 35 times at 92 'C for 1 min, 55"C 
for 1 min and 72"C for 1 min. The amplified products were
separi on an 1.6% agarose gel vism by
using Digoxigenin (DIG)
Mannheim). The PCR primers
amplification of TGF-pRII TGF-ßRIL mRNA are
described by Suzuki et air' Since these primers are located on 
both sides of the insertion, the PCR products of TGF-(iRII, 
or TGF-pRII: differ in size (525 bp and 601 bp, respectively) 
and show different mobility on an 1.6% agarose gel.
Induction of mild proteoglycan depletion
Mild PG depletion was induced in 10-week-old male
C57B1/6 mice by intra-articular injection of papain 
described by van der Kraan el al.M In short, the right 
knee-joints of the mice were injected once with 6 (.il 0.5% 
papain (Type IV, 15 U/mg, Sigma in 0.03 M L-cysteine.I-ICl, 
Sigma). The left control knees were injected with saline. At 
several points of time after the injection patellae were isolated 
and used for determination of patellar PG synthesis and 
RNA extraction for RT-PCR.
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Determination of patellar cartilage proteoglycan 
synthesis
Proteoglycan synthesis was measured ex vivo. Whole 
patellae, with a standard amount of surrounding tissue, were 
dissected from the knee joints. Patellae were pulse-labelled 
(2 h, 37"C) with psjsulfate (1.1 MBq/ml). After labelling the 
patellae were washed, fixed, decalcified, punched out of 
the surrounding tissue, dissolved and counted by liquid 
scintillation counting as described previously.3“1
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